Aptevo Therapeutics's market cap is currently $4.93M. The company's EPS TTM is $-8.4; its P/E ratio is ―; Aptevo Therapeutics is scheduled to report earnings on August 11, 2025, and the estimated EPS forecast is $-2.09. See an overview of income statement, balance sheet, and cash flow financials.
